Home › Peripheral Arterial Disease › Florida › Hialeah
Peripheral Arterial Disease clinical trials in Hialeah, FL
3 studies for Peripheral Arterial Disease are looking for participants at sites in and around Hialeah (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
RecruitingPhase 3
- Inpatient Research Clinic LLC, Miami Lakes · 4 mi away
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
RecruitingPhase 3
- Inpatient Research Clinic, Miami Lakes · 4 mi away
- Floridian Clinical Research, LLC, Miami Lakes · 4 mi away
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Family First Medical Research Center, Hialeah Gardens · 3 mi away
- Floridian Clinical Research, Miami Lakes · 4 mi away
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Boston, MA10 studies
- Cleveland, OH9 studies
- Dallas, TX9 studies
- Chicago, IL9 studies
- Houston, TX8 studies
- Gainesville, FL7 studies
- Minneapolis, MN6 studies
- Omaha, NE6 studies
- Miami, FL6 studies
- Nashville, TN6 studies
- Detroit, MI6 studies
- New Haven, CT5 studies
Other studies in Hialeah
- Schizophrenia13 studies
- Obesity13 studies
- Heart Failure12 studies
- Steatotic Liver Disease11 studies
- Type 2 Diabetes11 studies
- COPD10 studies
- Overweight10 studies
- Long COVID8 studies
- Viral Infections6 studies
- Lung Diseases6 studies
- Major Depressive Disorder6 studies
- Alzheimer's Disease6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.